This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,818.74 fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULES 100S, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD).
The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. It is not designated as a set-aside contract, indicating open competition.
AmerisourceBergen is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/4/25, 10:40 AM